Clorox Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Clorox wird ein jährliches Gewinn- und Umsatzwachstum von 21.6% bzw. 2.5% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 23.1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 151.8% betragen.

Wichtige Informationen

21.9%

Wachstumsrate der Gewinne

23.1%

EPS-Wachstumsrate

Household Products Gewinnwachstum8.2%
Wachstumsrate der Einnahmen2.2%
Zukünftige Eigenkapitalrendite177.0%
Analystenabdeckung

Good

Zuletzt aktualisiert15 Oct 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

An Intrinsic Calculation For The Clorox Company (NYSE:CLX) Suggests It's 40% Undervalued

Oct 07
An Intrinsic Calculation For The Clorox Company (NYSE:CLX) Suggests It's 40% Undervalued

Why We're Not Concerned About The Clorox Company's (NYSE:CLX) Share Price

Sep 21
Why We're Not Concerned About The Clorox Company's (NYSE:CLX) Share Price

Clorox: If You Need FMCG Player In A Portfolio - Look Elsewhere

Sep 15

Clorox (NYSE:CLX) Will Pay A Larger Dividend Than Last Year At $1.22

Aug 03
Clorox (NYSE:CLX) Will Pay A Larger Dividend Than Last Year At $1.22

Here's What To Make Of Clorox's (NYSE:CLX) Decelerating Rates Of Return

Jul 29
Here's What To Make Of Clorox's (NYSE:CLX) Decelerating Rates Of Return

Clorox: Stellar Delivery But Valuation Compression Has Some Distance To Go

Jul 29

Clorox: Questionable Growth Target Puts Me On The Sidelines

Jul 17

Clorox: Improving Outlook, Good Dividend Yield And Discounted Valuation

Jun 28

Is Clorox (NYSE:CLX) A Risky Investment?

May 25
Is Clorox (NYSE:CLX) A Risky Investment?

We Like The Quality Of Clorox's (NYSE:CLX) Earnings

May 07
We Like The Quality Of Clorox's (NYSE:CLX) Earnings

Clorox (NYSE:CLX) Could Be At Risk Of Shrinking As A Company

Apr 26
Clorox (NYSE:CLX) Could Be At Risk Of Shrinking As A Company

Colgate-Palmolive: Improved Financials To Navigate Headwinds (Rating Upgrade)

Apr 21

Is There An Opportunity With The Clorox Company's (NYSE:CLX) 31% Undervaluation?

Apr 10
Is There An Opportunity With The Clorox Company's (NYSE:CLX) 31% Undervaluation?

Is Clorox (NYSE:CLX) Using Too Much Debt?

Feb 09
Is Clorox (NYSE:CLX) Using Too Much Debt?

Clorox: Relatively Overvalued And Headwinds Put Dividend At Risk

Feb 08

The Clorox Company's (NYSE:CLX) Popularity With Investors Is Under Threat From Overpricing

Jan 25
The Clorox Company's (NYSE:CLX) Popularity With Investors Is Under Threat From Overpricing

Is The Clorox Company (NYSE:CLX) Trading At A 27% Discount?

Jan 07
Is The Clorox Company (NYSE:CLX) Trading At A 27% Discount?

Clorox: Not Wiped Out By Cyber Attack, Earnings And Revenue Need Cleaning Up

Jan 03

Be Wary Of Clorox (NYSE:CLX) And Its Returns On Capital

Dec 18
Be Wary Of Clorox (NYSE:CLX) And Its Returns On Capital

Clorox: One Of The Best Household Product Portfolios

Dec 01

The Clorox Company's (NYSE:CLX) CEO Might Not Expect Shareholders To Be So Generous This Year

Nov 09
The Clorox Company's (NYSE:CLX) CEO Might Not Expect Shareholders To Be So Generous This Year

Clorox: Undervalued But Too Many Red Flags

Oct 28

Clorox (NYSE:CLX) Seems To Use Debt Quite Sensibly

Oct 16
Clorox (NYSE:CLX) Seems To Use Debt Quite Sensibly

Clorox: Cyberattack Compounds Existing Challenges

Oct 10

Clorox's (NYSE:CLX) Shareholders Will Receive A Bigger Dividend Than Last Year

Oct 01
Clorox's (NYSE:CLX) Shareholders Will Receive A Bigger Dividend Than Last Year

Clorox: Still Struggling

Sep 25

Are Investors Undervaluing The Clorox Company (NYSE:CLX) By 35%?

Sep 21
Are Investors Undervaluing The Clorox Company (NYSE:CLX) By 35%?

Returns On Capital Signal Difficult Times Ahead For Clorox (NYSE:CLX)

Sep 03
Returns On Capital Signal Difficult Times Ahead For Clorox (NYSE:CLX)

The Clorox Company: The Necessary Clean-Up Has Only Begun

Aug 30

Despite Earnings Rally, Expectations On Clorox Are Low

Aug 15

Clorox's (NYSE:CLX) Upcoming Dividend Will Be Larger Than Last Year's

Jul 31
Clorox's (NYSE:CLX) Upcoming Dividend Will Be Larger Than Last Year's

Clorox: Stable Growth Prospects But Pricey

Jul 20

Clorox (NYSE:CLX) Has A Pretty Healthy Balance Sheet

Jul 15
Clorox (NYSE:CLX) Has A Pretty Healthy Balance Sheet

Keeping My Portfolio Clean By Avoiding Clorox

Jul 06

Colgate-Palmolive: Stagnation And Debt-Fueled Dividends

Jun 01

Here's What's Concerning About Clorox's (NYSE:CLX) Returns On Capital

May 31
Here's What's Concerning About Clorox's (NYSE:CLX) Returns On Capital

Estimating The Fair Value Of The Clorox Company (NYSE:CLX)

Apr 25
Estimating The Fair Value Of The Clorox Company (NYSE:CLX)

Clorox (NYSE:CLX) Has A Pretty Healthy Balance Sheet

Apr 07
Clorox (NYSE:CLX) Has A Pretty Healthy Balance Sheet

Clorox: Finally Emerging From The Pandemic Shadows

Feb 21

Clorox declares $1.18 dividend

Feb 15

The Clorox Company: Dividend Income Seekers Avoid Buying

Feb 09

Be Wary Of Clorox (NYSE:CLX) And Its Returns On Capital

Feb 05
Be Wary Of Clorox (NYSE:CLX) And Its Returns On Capital

Estimating The Intrinsic Value Of The Clorox Company (NYSE:CLX)

Jan 20
Estimating The Intrinsic Value Of The Clorox Company (NYSE:CLX)

Clorox (NYSE:CLX) Has A Pretty Healthy Balance Sheet

Jan 05
Clorox (NYSE:CLX) Has A Pretty Healthy Balance Sheet

The Clorox Company: High Valuations And Near-Term Headwinds Keep Me On The Sidelines

Dec 27

Gewinn- und Umsatzwachstumsprognosen

NYSE:CLX - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
6/30/20277,3949089781,32213
6/30/20267,1678419171,18218
6/30/20256,9847368501,12118
6/30/20247,093280483695N/A
3/31/20247,209240570785N/A
12/31/20237,31080728944N/A
9/30/20237,035867941,000N/A
6/30/20237,3891499301,158N/A
3/31/20237,171748401,063N/A
12/31/20227,065435721951N/A
9/30/20227,041405678923N/A
6/30/20227,107462535786N/A
3/31/20227,108458563834N/A
12/31/20217,080247580869N/A
9/30/20217,231437620934N/A
6/30/20217,3417109451,276N/A
3/31/20217,5229231,3051,633N/A
12/31/20207,5241,2251,3831,677N/A
9/30/20207,1311,1511,3891,658N/A
6/30/20206,7219391,2921,546N/A
3/31/20206,3658709661,195N/A
12/31/20196,1338168101,041N/A
9/30/20196,1578137801,004N/A
6/30/20196,214820786992N/A
3/31/20196,2787968001,003N/A
12/31/20186,2447909101,101N/A
9/30/20186,187841794975N/A
6/30/20186,124823782976N/A
3/31/20186,080808N/A962N/A
12/31/20176,040799N/A922N/A
9/30/20176,030716N/A958N/A
6/30/20175,973703N/A865N/A
3/31/20175,926666N/A813N/A
12/31/20165,875653N/A863N/A
9/30/20165,814654N/A801N/A
6/30/20165,761648N/A778N/A
3/31/20165,718672N/A826N/A
12/31/20155,693657N/A782N/A
9/30/20155,693634N/A778N/A
6/30/20155,655606N/A874N/A
3/31/20155,595588N/A832N/A
12/31/20145,560595N/A834N/A
9/30/20145,523585N/A832N/A
6/30/20145,514579N/A767N/A
3/31/20145,564592N/A720N/A
12/31/20135,611575N/A660N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: CLXDas prognostizierte Gewinnwachstum (21.6% pro Jahr) liegt über der Sparquote (2.5%).

Ertrag vs. Markt: CLXDie Erträge des Unternehmens (21.6% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (15.1% pro Jahr).

Hohe Wachstumserträge: CLXEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: CLXDie Einnahmen des Unternehmens (2.5% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.8% pro Jahr).

Hohe Wachstumseinnahmen: CLXDie Einnahmen des Unternehmens (2.5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: CLXDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich sehr hoch sein (151.8%).


Wachstumsunternehmen entdecken